Halozyme Therapeutics | HALO - Market Capitalization


Halozyme Therapeutics reported $8.08B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 290M 51M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
DBV Technologies USD 274M 17M Sep/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
MannKind USD 1.74B 93M Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Pfizer USD 141.57B 6.48B Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024